Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07531316 · ClinicalTrials.gov registry record · Phase 1
Safety and Tolerability Study of VVZ-2471 in Healthy Volunteers
A Phase 1 study, sponsored by Virginia Commonwealth University.
- Not yet
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT07531316 is a Phase 1 study that has not yet begun recruiting, run by Virginia Commonwealth University. The registered enrollment target is 60 participants.
The verdict
NCT07531316, a Phase 1 study, has not yet begun recruiting, sponsored by Virginia Commonwealth University.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
The goal of this study is to do follow-up safety testing and how well people are able tolerate an experimental (not FDA approved) medication . This study is seeking non-illicit drug using adults to test the medication. Results of this study will help us to develop future studies to test the medication with people who use substances.
Interventions
- DRUG Placebo pills for 14-day intervention
- DRUG VVZ-2471 for 14-day intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-07-15 |
| Est. Completion | 2031-12-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07531316
The ClinicalTrials.gov registry entry for NCT07531316 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo pills for 14-day intervention is the first listed.
NCT07531316 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07531316 about?
NCT07531316 is a clinical study titled "Safety and Tolerability Study of VVZ-2471 in Healthy Volunteers". The goal of this study is to do follow-up safety testing and how well people are able tolerate an experimental (not FDA approved) medication . This study is seeking non-illicit drug using adults to test the medication. Results of this study will help us to develop future studies to test the medicati...
What is the current status of trial NCT07531316?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2026-07-15. Estimated completion is 2031-12-30.
What interventions are being tested in trial NCT07531316?
The interventions under investigation include: Placebo pills for 14-day intervention (DRUG), VVZ-2471 for 14-day intervention (DRUG).
Who is sponsoring clinical trial NCT07531316?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.